Alzheimer's disease impacts minority communities at higher rates, underscoring significant health disparities influenced by socioeconomic status, healthcare access, and education. African Americans face nearly double the risk, while Hispanics are 1.5 times more likely to develop Alzheimer's than non-Hispanic whites. These gaps are intensified by lower disease awareness, delayed diagnoses, and reduced clinical trial participation within these populations. Contributing factors include poverty, limited access to healthy food, and educational disparities. To combat these issues, efforts must focus on culturally sensitive education, better healthcare accessibility, and diverse research participation to ensure effective, inclusive treatment strategies.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States